Exosome-like vesicles (ELVs) are a novel class of biomarkers that are receiving a lot of attention for the detection of cancer in an early stage. In this study the feasibility of using a Surface Enhanced Raman Spectroscopy (SERS) based method to distinguish between ELVs derived from different cellular origins is evaluated. A gold nanoparticle based shell is deposited on the surface of ELVs derived from cancerous and healthy cells which enhances the Raman signal while maintaining a colloidal suspension of individual vesicles. This nano-coating allows the recording of SERS spectra from single vesicles. By using Partial Least Square Discriminative Analysis (PLS-DA) on the obtained spectra, vesicles from different origin can be distinguished, even when present in the same mixture. This proof-of-concept study paves the way for non-invasive (cancer) diagnostic tools based on exosomal SERS fingerprinting in combination with multivariate statistical analysis.
Introduction
To maximize the impact of current cancer treatments it is essential to detect carcinogenic cells in an early stage. To this end, the discovery of sufficiently sensitive and specific biomarkers is of foremost importance. Recently, circulating extracellular vesicles (EVs), especially exosomes, have emerged as a potential new class of biomarkers for early detection and treatment monitoring in cancer and other diseases. [1, 2] Exosomes are small (40-200 nm in diameter) membranous vesicles actively released by cells. They are composed of a protein-lipid bilayer encapsulating an aqueous core comprising nucleic acids and soluble proteins. Exosomes typically originate from the endosomal pathway. By inward budding of late endosomes, multivesicular bodies are formed which then fuse with the limiting membrane of the cell concomitantly releasing the exosomes. [3] This mechanism allows the cell to discard waste material [4, 5] and is associated with intercellular communication. [6, 7] Exosomes are of interest for diagnostic and prognostic applications as they contain molecules derived directly from the parent cell. [8] In addition, they are fairly easily accessible as they are found in various body fluids (e.g. blood, salvia, urine, breast milk, ascites, etc.). [9] [10] [11] Currently, most exosome based diagnostic approaches focus on identifying specific molecular components by elaborate 'omics' studies. [12] Examples are elevated levels of miR-21 in exosomes of hepatocellular cancer patients [13] and the presence of EGFRvIII mutant proteins on exosomes derived from a specific glioblastoma subtype. [14] Despite the fact that these techniques provide detailed information on the molecular composition of exosomes, they rely on complicated and timeconsuming protocols. Moreover, these analyses are performed on the overall EV population level which makes it less likely to find low abundant subpopulations. Indeed, considering that most cells secrete EVs as part of their normal function, it is to be expected that the amount of vesicles derived from diseased cells is comparatively low. Accordingly, the detection of altered levels of low abundant components in a bulk analysis is quite challenging. Furthermore, it is becoming apparent that one cell type may release multiple subtypes of EVs due to which bulk analysis is prone to missing specific subtypes or subtype ratios of vesicles. [15] [16] [17] Therefore, techniques capable of identifying individual exosomes could prove very valuable, but are currently lacking.
In this manuscript, a new approach is explored for single exosome identification based on surface enhanced Raman spectroscopy (SERS) for diagnostic applications. Raman spectroscopy is a labelfree technique based on inelastic scattering of laser light due to interaction of photons with molecular vibrations. As such, the Raman spectrum of inelastically scattered photons contains information on the molecular composition of the sample. Raman spectroscopy has been used before to characterize EVs. [18, 19] However, as it is a very inefficient process (only 1 in 10 [6] [7] [8] photons is scattered inelastically), a high sample concentration is required in combination with high laser power and long signal integration times. High throughput screening of single vesicles by Raman spectroscopy is therefore not feasible. [20] Fortunately, the Raman signal can be strongly enhanced (up to 10 [14] [15] times) by using SERS. [21] SERS is based on the enhancement of the incident and scattered electromagnetic field by plasmon excitation on irregular (metal) surfaces, typically composed of Au or Ag. [22] [23] [24] As it has single molecule sensitivity, SERS is increasingly applied for the characterization of biological samples. [25, 26] In this respect, different types of SERS-substrates have been developed to obtain plasmon enhancement and record Raman spectra from (sub)cellular components down to the single biomolecule level. [27] These can be, but are not limited to, well defined nanostructured surfaces of gold [28] or silver [29] and (intracellular) aggregated Ag [30] or AuNP [31] . Both Ag-nanograin coated chips and precipitated AuNP clusters were recently applied for bulk EV measurements. [32, 33] These few reports show the feasibility of obtaining SERS spectra from an EV sample and the capability to differentiate between EVs from different origin. [32, 33] However, it is important to note that these previous analyses were still performed on bulk vesicles from a single cell type. Yet, clinical samples contain EVs from different origin in a mixture, hampering the further implementation of bulk Raman measurements for diagnostic applications.
To enable true single vesicle SERS identification, here we demonstrate to the best of our knowledge for the first time, that EVs can be functionalized with gold nanoparticles (AuNP) on their surface, forming an irregularly shaped nanoshell that enables the generation of an enhanced Raman signal while maintaining a colloidal suspension of individual vesicles. As proof-of-concept of the diagnostic potential of this approach, we show that vesicles derived from B16F10 melanoma cells can be successfully identified and quantified in a mixture with red blood cell (RBC)-derived vesicles.
Results

Exosome-like vesicle (ELV) purification and characterization
The potential of SERS to distinguish between vesicles released by two distinct cell types was explored using ELVs from RBC and B16F10 melanoma cancer cells. The terminology ELVs is further used throughout the manuscript as it is to date impossible to conclusively claim that all purified vesicles are originating from the endosomal cell compartment and consequently can be termed exosomes. [34] To this end, it is more appropriate to use the term ELVs. B16F10 cells were cultured in vitro and after 24 h incubation, the conditioned cell medium was harvested and used for ELV purification. An iodixanol density gradient based ultracentrifugation (UC) protocol was used ( Figure S1 ) to obtain ELVs with a high purity with minimal protein contamination ( Figure S2 ) [35] or residuals of commercial precipitation kit reagents. [36] After density gradient UC the fraction containing the ELVs was determined by immunoblotting against typical exosome-associated protein markers (HSP70, β-actin, CD63, CD81) on each fraction of the density gradient. [37] In this respect, fraction 5 contained the highest amount of exosomal markers. Moreover, the average density of this fraction was 1.14 g/ml which corresponds with earlier reports on the typical buoyant density of exosomes ( Figure 1A) . [38] This fraction was used further for characterization and Raman spectroscopy experiments. As a 'healthy' vesicle source, RBC were used as they are abundantly present in patient-derived blood samples. The same ELV purification protocol was used as described for the B16F10 melanoma cell-derived vesicles ( Figure S1 ).
After two additional washing steps by UC, the ELV pellet was suspended in ultrapure water (Millipore) and analyzed for size and zeta potential by single particle tracking analysis and dynamic light scattering, respectively. The majority of the B16F10 melanoma-derived ELVs had a hydrodynamic diameter of approx. 0.12 µm. RBC-derived vesicles were slightly larger with a size of approx. 0.17 µm (Figure 1B ). Both types of vesicles had a negative surface charge ( Figure 1B) .
Finally, cryo-TEM was used as an additional confirmation of the presence of membranous structures in the purified samples ( Figure 1C) . Figure 1 . Characterization of purified B16F10 melanoma-and RBC-derived ELVs. A) Immunoblotting against exosomal markers HSP70, β-actin, CD63 and CD81 on the different density fractions after overnight density gradient UC of B16F10 melanoma derived conditioned medium. For each fraction the average density is reported [g/ml]. B) Representative size (upper) and zeta potential (lower) of B16F10 melanoma-(black) and RBC-(gray) derived ELVs determined by single particle tracking analysis and dynamic light scattering, respectively. C) Cryo-TEM images of B16F10 melanoma (left) and RBC-derived (right) ELVs. The scale bar indicates 100 nm.
Gold nanoparticle coating of ELVs
As a next step, we investigated if it would be possible to coat ELVs with AuNP while maintaining a colloidal single vesicle suspension. Specifically, we explored a coating strategy that is based on the electrostatic adsorption of cationic (due to a 4-dimethylaminopyridine (DMAP) coating), 10 nm AuNP (Figure S3A and S3B) onto the anionic surface of ELVs. AuNP were mixed with vesicles at increasing particle over vesicle ratios. It was observed that increasing the ratio of . To obtain a SERS signal, AuNP need to be in close proximity to one another. [24] In this respect, high amounts of AuNP to vesicles were mixed (i.e. ~800 for B16F10 and ~1200 for RBC) for the SERS measurements. Indeed, for these higher ratios, cryo-TEM imaging showed nearly complete coating of both vesicle types with AuNP ( Figure 2C and 2D). 
Recording SERS spectra of individual ELVs
Next, we investigated if this dense packing of AuNP on the vesicular surface indeed allows to generate a SERS spectral fingerprint. For these experiments we worked under high AuNP:vesicle ratios as described above. Spectra were recorded from individual AuNP coated ELVs adsorbed on a quartz surface ( Figure 3A ). Peaks from (exosomal) biomolecules (green arrows) could be clearly identified in the spectra from B16F10 melanoma-derived vesicles ( Figure 3B ) and RBC-derived vesicles ( Figure 3C ), apart from peaks arising from the DMAP coating of the AuNP (red arrows; cfr. Figure S4) . Table 1 
Identification of individual ELVs by spectral analysis
The obtained Raman spectra were subjected to two previously published dedicated statistical models: a Partial Least Square Discriminative Analysis (PLS-DA) and a Multivariate Curve Resolution Alternating Least Squares (MCR-ALS). [39, 40] Both models were trained and calibrated by Raman spectra obtained from pure samples i.e. AuNP alone, AuNP coated B16F10-derived vesicles and AuNP coated RBC-derived vesicles. The potential of Raman spectroscopy to discriminate between B16F10 melanoma and RBC-derived ELVs in an unbiased fashion was quantified by the PLS-DA model. A sensitivity of 95.8%, 88.0%, 95.1% and specificity of 95.5%, 95.4% and 98.0% for AuNP, B16F10 and RBC-derived ELVs, respectively was obtained ( Table   2 ). The here reported specificity and sensitivity of the model to discriminate among the different types of vesicles was assessed by cross-validation. Moreover, a parallel experiment was performed with a different Raman microscope allowing shorter acquisition times (500 ms compared to 10 s for the above measurements). Analysis of the obtained data was again performed using the PLS-DA model. The results show that the ability to separate between samples based on their SERS fingerprint was maintained (Table S1 ).
Additionally, a MCR-ALS algorithm was applied on the obtained spectra ( Figure S5 ). Here it is important to note that the MCR-ALS model requires minimal constraints and prior information about the sample and is an unsupervised methodology. Nonetheless, the algorithm was able to deconvolve spectra ( Figure S5A ) which can be attributed (based on the score plots represented in Figure S5B and spectra in Figure 3 ) to: Quartz (surface), DMAP (AuNP coating), B16F10 and RBC vesicles respectively. Indeed, this objectively shows the spectral discrepancy between ELVs from different origin.
Identification and quantification of B16F10 vesicles in a mixture with RBC-derived vesicles
Finally, to provide evidence of the diagnostic potential of this approach, mixtures of AuNP functionalized B16F10 cancerous-and RBC-derived ELVs were prepared at two different ratios.
This setup more closely resembles the in vivo situation where cancerous vesicles need to be detected in patient samples containing a variety of vesicle types, especially highly abundant RBCderived ELVs. To determine as a reference the exact ratio of both types of vesicles in the prepared mixtures, they were fluorescently labeled with lipophilic dyes (RBC ELVs = green; B16F10 ELVs = red) and subsequently coated with AuNP. The suspension was placed on a microscopy cover slip and confocal microscopy images were recorded. With in-house developed particle detection software the number of green and red fluorescent spots were counted ( Figure S6A ). It was calculated that mixture 1 contained 51 ± 17 % cancerous ELVs and mixture 2 contained 15 ± 6% cancerous ELVs, respectively ( Figure S6B ). From these images it could also be confirmed that the two types of AuNP coated vesicles did not agglomerate with one another as no co-localization of green and red spots could be seen.
Identical mixtures without fluorescent labels were subsequently prepared for SERS measurements. 
Discussion
In this manuscript we investigated the possibility of identifying single ELVs by SERS. In contrast to previous diagnostic approaches, where the focus lies on detecting the presence or modified expression of a single exosomal component (i.e. a specific nucleic acid, lipid or protein) [41] using elaborate and time-consuming 'omics' studies, here the potential of SERS was tested to generate an optical fingerprint of individual ELVs coated with AuNP. If successful, such a method holds great potential for the identification of vesicles from different cellular origin in a quantitative manner from patient samples.
As an initial proof-of-concept, vesicles were purified from two distinct cell types. A skin-derived, B16F10 melanoma cell line was used as a model for carcinogenic cells and primary RBC as a model for healthy cells that are highly abundant in blood samples. To obtain vesicular concentrates as pure as possible, an iodixanol based density gradient UC protocol was used. [35] This is essential as it was previously shown that residuals of commercial purification kits can interfere with the Raman fingerprint. [36] Moreover, other less stringent purification protocols (i.e. UC and commercial precipitation kits) suffer from limited purity due to co-purification of vesicleindependent proteins and nucleic acids, which might preclude the AuNP from interacting with the ELVs [42] and interfere with the Raman fingerprint.
In a next step, the purified vesicles were functionalized with ~10 nm AuNP to generate the SERS signal. The small diameter ensures that a large number of hot-spots are created in close proximity to the ELV-surface. The AuNP carry a cationic surface charge due to the DMAP coating which allows adsorption onto the anionic ELVs surface. Likely this association is charge based though it is also possible that the DMAP-molecules are exchanged for thiol-containing proteins present on the ELV surface. [43] Although aggregation was observed initially at low AuNP:vesicle ratios, at higher ratios a colloidal suspension of individual AuNP coated vesicles could be obtained. Indeed, once the overall surface charge of the AuNP coated ELVs became firmly positive (due to the DMAP coating), a mutual repulsion between the coated vesicles was created. This was confirmed using dynamic light scattering, cryo-electron microscopy and indirectly by confocal fluorescence microscopy. Additionally, as DMAP is a small molecule, the AuNP can reside in close proximity to the ELV surface. To the best of our knowledge this is the first time that single ELVs were enveloped with a gold coating. On average ~800 AuNP were used to coat the B16F10 melanoma vesicles, while ~1200 for RBC vesicles which is in agreement with the fact that RBC ELVs have a larger surface area and approaches the theoretical amount of AuNP to create a monolayer. This nanoshell of AuNP allowed to generate a SERS signal emanating from the ELVs due to a strong localized surface plasmon resonance between the closely packed AuNP present on the vesicular surface. [44] The Raman peaks in the SERS spectra of single ELVs were found to arise in part from the DMAP and from ELV biomolecular components that are present in the vicinity of the AuNP. Biomolecular exosomal components were identified at 1123 cm (nucleic acids). Interestingly, most of these pronounced peaks have previously been identified by others when recording Raman spectra of biological samples like erythrocytes [45] or even EVs (by classic Raman or SERS on bulk isolates). [18, 19, 32, 33, 36] Next, we could show that the generated spectra, in combination with a PLS-DA classification model, allow us to separate between vesicles derived from B16F10 melanoma cells and RBCderived vesicles. The fact that Raman spectroscopy is able to discriminate between vesicles from different cellular origin is in accordance with the very few reports available to date in which it was shown that classic Raman spectroscopy [18] and SERS [32, 33] on bulk or clusters of vesicles has discriminative power, even for more similar parent cells. Yet, as mentioned above, these reports are based on pure samples of one type of EV measured in bulk. Here, instead, we tackled the pending challenge of using SERS for the identification and quantification of single cancerous ELVs that are present in a mixture with 'healthy' RBC-derived vesicles. While future research should focus on testing more complex mixtures with multiple types of vesicles, still this is a promising proof-of-concept study. We consider the subtle difference discriminated by SERS in previous work on bulk EVs as a promising indication that detecting cancerous ELVs in complex mixtures would be possible with our single vesicle SERS approach. [28] It is of note that an alternative approach with the potential of single vesicle SERS was very recently developed by Lee et al.. Their setup is based on Ag coated 'nanobowls' for hot-spot generation and SERS fingerprinting of EVs deposited into the nanobowls. [36] While a complex technological feat, our approach benefits from its simplicity and high-throughput potential. The AuNP based shell is formed by simple self-assembly and AuNP functionalized ELVs can be measured by standard Raman equipment. Furthermore, our approach can be easily combined with (standard) microfluidics and an optical trapping unit allowing automated and fast SERS measurements. These characteristics will help to overcome the technological challenge of upscaling this technology for future clinical applications.
With the most sensitive set-up we could record clear Raman spectra at 0.5 s integration time per ELV. This means that per day it would be possible to analyze about 160.000 individual ELVs. As detectors continue to become more sensitive, and combined with the fact that a 0.5 s integration period already gave a strong and clear Raman spectrum, we expect that throughput could be increased 5-10 fold in the near future. Rapid recording of single spectra is indeed of pivotal importance for potential future diagnostic applications as 'diseased' ELVs are likely present in low abundance relative to the 'healthy' ones.
A particular challenge with our new approach is that SERS spectra of individual ELVs exhibit quite some variability, even for vesicles of the same parent cell. This originates from variability within the ELV population but potentially also from the (random) adsorption of AuNP on the vesicle surface and non-uniformity in hot spot generation. [46] In future research, therefore, it will be of interest to investigate other ways of functionalizing vesicles with AuNP with the aim to make the SERS spectra more uniform among vesicles of the same origin. This would allow to detect more subtle differences in molecular compositions and obtain more reliable molecular information from each individual vesicle. In turn this will lead to even better specificity and sensitivity. Apart from diagnostic applications, this method has the potential of being useful to deepen insight in molecular composition/diversity of the vesicles secreted by a certain cell type. [15] 
Conclusion
Our findings show that applying SERS technology on AuNP-coated ELVs in combination with PLS-DA is capable of sensing biomolecular diversity between ELVs from different origins.
Although future research should focus on more complex ELV mixtures, we have clearly demonstrated the potential of single vesicle identification by SERS to obtain ratios of vesicles from different origins in a mixture.
Experimental Section
Cell culturing and ELV purification
B16F10 melanoma cells (ATCC® CRL-6475™) were cultured in Dulbecco's Modified Eagle
Medium (Invitrogen), supplemented with glutamine (2 mM), 10 % heat-inactivated fetal bovine serum (Hyclone), Sodium Pyruvate (1 mM), penicillin (100 U/mL) and streptomycin (100 µg/ml ) (Invitrogen) at 37 °C in a humidified atmosphere containing 5 % CO2. For the purification of ELVs, cells were first washed with phosphate-buffered saline (PBS, Invitrogen) and the cell medium was replaced with vesicle-depleted medium. The latter was prepared by ultrafiltration of complete cell culture medium through a 300 kDa filter (Millipore) using an Amicon stirred cell setup (Millipore) under three bar nitrogen pressure to remove bovine EVs. Cells were incubated for 24 hours after which the conditioned cell medium was harvested for vesicle purification.
Red blood cells (RBC) were isolated out of blood from a healthy volunteer as described previously [47] with minor modifications. Briefly, blood was collected in K2EDTA coated tubes (Venosafe) and spun at 1 500 g for 15 minutes (Heraeus Multifuge 1S-R) within 10 minutes after blood collection. RBC were retained, washed twice and suspended in Ringer buffer (NaCl (150 mM), KCl (5 mM), CaCl2 (2 mM), MgCl2 (1mM), NaH2PO4 (2 mM), 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES)-buffer (10 mM), Glucose (10 mM), pH=7.2) for 2 days at 37°C while shaking.
Vesicles derived from B16F10 melanoma cells and RBC were purified from conditioned cell medium or Ringer buffer, respectively by differential centrifugation followed by density gradient UC (figure S1). First, conditioned cell medium/Ringer buffer was centrifuged for 10 minutes at 300 g and 10 minutes at 3 000 g. Next, the supernatant was concentrated by ultrafiltration using a 30 kDa filter (Millipore) in a Amicon stirred cell setup (Millipore) under nitrogen pressure. The concentrated sample was centrifuged (Beckman® L8-70M ultracentrifuge) at 10 000 g for 10 minutes using a SW55ti rotor (Beckman instruments) and the supernatant was placed on top of an iodixanol (Optiprep, Axis-Shield) based density gradient. The gradient was produced according to the manufacturer's instruction. Briefly, 1 ml of different iodixanol dilutions (12.5 %, 25 %, 37.5 % and 50 % in sucrose (250 mM), EDTA (1 mM), Tris-HCl (10 mM) buffer; pH = 7.4) were carefully laid underneath one another using a 21G needle. The samples were then centrifuged at 150 000 g for 15 hours. Next, the gradient was fractionated per 0.5 ml, diluted 10x in ultrapure water and centrifuged at 150 000 g for 150 minutes. Finally, the pellet was washed 1 more time and suspended in ultrapure water. The fraction containing the exosome associated proteins was used for further characterization and Raman spectroscopy experiments and the respective vesicles are referred to as ELVs.
Immunoblotting
In order to determine the density fraction containing the exosomes, pelleted vesicles from each fraction were resuspended in ice cold RIPA buffer (Sigma-Aldrich) mixed with MS-SAFE protease and phosphatase inhibitor cocktail (Sigma-Aldrich) and vortexed. Next, the samples were sonicated for 10 minutes and centrifuged at 13 000 g for 5 minutes. For protein separation, samples were diluted in 2x Laemmli buffer (Bio-Rad) with or without 5 % 2-mercaptoethanol (Sigma-Aldrich), heated at 95°C for 5 minutes and loaded on a 10 % mini-protean TGX precasted gel (Bio-Rad). in PBS buffer (Invitrogen). Next, primary antibodies were incubated overnight at 4°C on a shaker.
After washing the blots with blocking buffer they were incubated with a secondary antibody conjugated to HRP for 1 hour at room temperature (Table S2 ). Visualization was done using the SuperSignal West Dura chemiluminscent kit (Thermo-Scientific) in combination with a VersaDocTM imaging system (Bio-Rad). All density fractions were loaded on one gel using equal volumes for objective comparison and the respective protein bands were cropped and aligned underneath one another for clarity.
DMAP coated AuNP
AuNP coated with DMAP were prepared as described by Gittins and Caruso. [48] Briefly, a HAuCl4 aqueous solution was added to a tetraoctylammonium bromide in toluene solution under gentle stirring. Next, NaBH4 was added to the mixture. After 30 minutes the toluene phase was separated from the aqueous phase and washed 3 times using H2SO4, NaOH and ultrapure water. Equal . [49] ln 3.3211 ln 10.80505
In which  represents the molar extinction coefficient and d the diameter of the AuNP (10 nm).
AuNP coating of ELVs
ELVs were mixed with DMAP coated AuNP at different AuNP:vesicle ratios by mixing equal volumes using a pipette. After 10 minutes incubation at room temperature, the samples were diluted in ultrapure water/buffer and analyzed by different techniques (i.e. dynamic light scattering and cryo-TEM).
Concentration, size and zeta potential measurements
The concentration and size distribution of purified ELVs was determined by light scattering based single particle tracking using a NanoSight LM10 instrument (Malvern instruments Ltd.) equipped with a 405 nm laser. Prior to analysis, the concentrated vesicles were diluted in HEPES buffer (pH The size and zeta potential of ELVs and ELVs coated with AuNP (after dilution in HEPES-buffer)
were measured by dynamic light scattering using a Zetasizer Nano ZS (Malvern instruments Ltd.), equipped with Dispersion Technology Software.
Cryo-transmission electron microscopy
Each ELV (with our without AuNP) sample (3.5 µL) was applied to a 300 mesh quantifoil grid and incubated for 30-60 seconds. Next, excess buffer was removed by blotting the grids for 3 seconds using a Whatmann 1 filter paper and the sample was snap frozen by plunging in liquid ethane at a temperature of -180°C and stored in liquid nitrogen until visualization. Next, the samples were transferred to a Gatan 914 cryoholder and imaged at low dose conditions at -177°C, using a JEOL JEM1400 TEM equipped with a 11 Mpxl Olympus SIS Quemesa camera.
Fluorescent labeling and confocal microscopy of ELVs
Purified B16F10-and RBC-derived vesicles were incubated for 15 minutes at 37°C with Vibrant DiD (Invitrogen) or PKH67 (Sigma), respectively (final dye concentration = 5 µM; in Diluent C (Sigma)). Next, non-incorporated dye and diluent C was removed using exosome spin columns (MWCO 3 000) pre-incubated with ultrapure water according to the manufacturer's instructions (Invitrogen).
The labeled ELVs were mixed with AuNP in the indicated ratios (cfr. SERS measurements) and visualized using a swept field confocal microscope (LiveScan SFC, Nikon Belux) equipped with a 60x oil immersion lens (NA = 1.4, Nikon). The ELVs were alternately irradiated with 488 nm and 647 nm laser light and images were recorded with an iXon Ultra EMCCD camera (Andor). Particle detection was done with in-house developed software in Matlab as previously described by
Deschout et al.. [50] The ratio of B16F10 to RBC vesicles (B16F10:RBC ratio) was determined for each mixture by particle counting in at least 20 individual images at different spatial locations.
SERS measurements
ELVs (unlabeled) were mixed with DMAP coated AuNP at a fixed AuNP:vesicle ratio (i.e. ~800
for B16F10-derived ELVs and ~1200 for RBC-derived ELVs). Next, samples were diluted in ultrapure water to ≤ 5 x 10 7 vesicles per µl to minimize the possibility that more than one vesicle is present in the focal detection volume. A droplet (60 µl) of the diluted sample was placed on a quartz substrate and SERS spectra were recorded using an inVia confocal Raman microscope (Renishaw, UK) equipped with a 60x WI lens (NA = 1, Nikon) and a 785 nm laser using a 10 second integration time and 15 mW power. Alternatively, a Raman microscope (Zeiss) equipped with a piezo-scanner (P500, physick instrumente) and a 785 nm laser focused through a 60x WI lens (NA = 1, Nikon) was used (integration time 500 ms). The spectra were acquired with a Spectra Pro500i (Acton Research) monochromator/spectrograph. The 785 nm laser was chosen to limit photodegradation and autofluorescence. [51, 52] All spectra were recorded at different locations in the sample. The presence of a gold coated ELV in the focal volume was confirmed by light scattering (figure 3A).
Analysis of SERS spectra
For statistical analysis, the obtained spectra were pre-processed as described previously. [39] To assess the ability of Raman spectroscopy to discriminate RBC-and B16F10 melanoma-derived ELVs, PLS-DA was performed using the PLS toolbox from Eigenvector Research in MatLab.
Cross-validation analysis was computed by Venetian blinds (10 splits and one sample per split).
The number of retained latent variables was chosen to minimize the root mean square error of cross validation curves. Additionally, a MCR-ALS algorithm was used to analyze the spectra. ToC. A method to obtain a surface enhanced Raman spectrum (SERS) of a single, nano-sized exosome-like vesicle (ELV) while maintaining individual ELVs in suspension. Based on these spectra ELVs derived from different cell types can be distinguished, hence allowing the identification and quantification of specific (cancerous) ELVs in a mixture. Figure S1 . Schematic representation of the protocol used to purify exosome-like vesicles (ELVs) from conditioned cell medium. Figure S2 . Comparison of the purity of B16F10-derived ELV isolations obtained by density gradient UC or UC alone, respectively. The purity is expressed as the amount of particles (determined by single particle tracking; NanoSight) per µg protein (determined by Pierce BCA protein assay kit; ThermoFisher Scientific) as recommended by Webber et al.. . n Represents the amount of spectra allocated to a specific class within a mixture. For the first mixture 77 spectra were recorded, For the second mixture 65 spectra were recorded. Table S1 . PLS-DA classification of the spectra of pure samples recorded with an integration time of 500 ms. n is the amount of spectra recorded for each sample The secondary antibody is linked to a HRP-enzyme; b)
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Reducing conditions imply heating of the sample to 95 °C for 5 minutes in the presence of 2-mercaptoethanol Supporting equation
. Equation used to calculate the theoretical average amount of AuNP needed to coat an entire vesicle surface in a monolayer, with n as the total amount of vesicles, SELV,i as the surface of a vesicle i, ɳ is the maximum packing density of a sphere which was fixed at 0.9 (hexagonal packing was assumed) and SSAuNP as the surface of the section occupied by one AuNP. Calculations were based on the size distribution for each ELV type as depicted in figure 1B .
